⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRDF News
Cardiff Oncology, Inc. Common Stock
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
CRDF
Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity
globenewswire.com
CRDF
Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026
globenewswire.com
CRDF
Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting
globenewswire.com
CRDF
Form 8-K
sec.gov
CRDF
Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth
globenewswire.com
CRDF
Form 8-K
sec.gov
CRDF
Web Agency Summit Announces 2026 Keynote Lineup Featuring Semrush, WordPress, and Crowd Favorite
globenewswire.com
SEMR
GOOGL
CRDF
Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer
globenewswire.com
CRDF
Cardiff Oncology to Present Preclinical Data with Highly Specific PLK1 Inhibitor Onvansertib at the 2026 AACR Annual Meeting
globenewswire.com
CRDF